Risperidone 12.5 MG Injection — RxCUI 706822
RxNorm drug concept · Semantic clinical drug
RxCUI 706822
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI706822
Official nameRisperidone 12.5 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asrisperiDONE 12.5 MG Extended Release Injection
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)44,565 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Risperidone Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That's a really common question. The injection is a long-acting, extended-release form of risperidone — it slowly releases medication from the injection site over time, so you don'...
- Why do I need an injection instead of just taking a pill every day?
- Great question — this trips a lot of people up. The injection takes a little time to fully kick in because it releases medication slowly from a depot under the skin. To make sure y...
- Why do I have to take pills for the first few weeks after starting the injection?
🕸️ Concept Web — How Risperidone 12.5 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Risperidone 12.5 MG Injection
RxCUI 706822 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Risperidone
35636IN
-
Risperidone
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Risperdal
152318BN -
Rykindo
2639728BN
-
Risperdal
-
Dose forms 8
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Risperidone Injection
1743574SCDF -
Risperidone Injectable Product
1165478SCDG -
Risperidone Injection [Risperdal]
1743577SBDF -
Risperidone Injection [Rykindo]
2639731SBDF -
Risperdal Injectable Product
1185339SBDG -
Rykindo Injectable Product
2639730SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Risperidone Injection
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Risperidone 12.5 MG
1743573SCDC -
Risperidone 12.5 MG Injection [Risperdal]
706825SBD -
Risperidone 12.5 MG Injection [Rykindo]
2639732SBD -
Risperidone 12.5 MG [Risperdal]
1743576SBDC -
Risperidone 12.5 MG [Rykindo]
2639729SBDC
-
Risperidone 12.5 MG
Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Risperidone 12.5 MG
SCDC · 1743573 -
Risperidone Injection
SCDF · 1743574 -
Risperidone Injectable Product
SCDG · 1165478
Brand-Name Concepts
-
Risperidone 12.5 MG Injection [Risperdal]
SBD · 706825 -
Risperidone 12.5 MG Injection [Rykindo]
SBD · 2639732 -
Risperidone 12.5 MG [Risperdal]
SBDC · 1743576 -
Risperidone 12.5 MG [Rykindo]
SBDC · 2639729 -
Risperidone Injection [Risperdal]
SBDF · 1743577 -
Risperidone Injection [Rykindo]
SBDF · 2639731 -
Risperdal Injectable Product
SBDG · 1185339 -
Rykindo Injectable Product
SBDG · 2639730 -
Risperdal
BN · 152318 -
Rykindo
BN · 2639728
📦 FDA Products & Package NDCs
12 products · 12 package NDCs
12 package NDCs map to RxCUI 706822 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00480-1232-08 | 1 KIT in 1 CARTON (0480-1232-08) * 2 mL in 1 VIAL (0480-97... | Risperidone | Teva Pharmaceuticals, Inc. | 2023-12-11 |
| 00480-1342-08 | 1 KIT in 1 CARTON (0480-1342-08) * 2 mL in 1 VIAL (0480-97... | Risperidone | Teva Pharmaceuticals, Inc. | 2023-12-11 |
| 00480-1453-08 | 1 KIT in 1 CARTON (0480-1453-08) * 2 mL in 1 VIAL (0480-97... | Risperidone | Teva Pharmaceuticals, Inc. | 2023-12-11 |
| 00480-1554-08 | 1 KIT in 1 CARTON (0480-1554-08) * 2 mL in 1 VIAL (0480-97... | Risperidone | Teva Pharmaceuticals, Inc. | 2023-12-11 |
| 50458-0306-11 | 1 KIT in 1 BOX (50458-306-11) * 2 mL in 1 SYRINGE (50458-3... | RISPERDAL CONSTA | Janssen Pharmaceuticals, Inc. | 2003-10-29 |
| 50458-0307-11 | 1 KIT in 1 BOX (50458-307-11) * 2 mL in 1 VIAL * 2 mL in... | RISPERDAL CONSTA | Janssen Pharmaceuticals, Inc. | 2003-10-29 |
| 50458-0308-11 | 1 KIT in 1 BOX (50458-308-11) * 2 mL in 1 VIAL * 2 mL in... | RISPERDAL CONSTA | Janssen Pharmaceuticals, Inc. | 2003-10-29 |
| 50458-0309-11 | 1 KIT in 1 BOX (50458-309-11) * 2 mL in 1 VIAL * 2 mL in... | RISPERDAL CONSTA | Janssen Pharmaceuticals, Inc. | 2003-10-29 |
| 70121-2625-05 | 1 KIT in 1 CARTON (70121-2625-5) * 2 mL in 1 VIAL (70121-1... | Risperidone | Amneal Pharmaceuticals LLC | 2025-09-08 |
| 70121-2626-05 | 1 KIT in 1 CARTON (70121-2626-5) * 2 mL in 1 SYRINGE (7012... | Risperidone | Amneal Pharmaceuticals LLC | 2025-09-08 |
| 70121-2627-05 | 1 KIT in 1 CARTON (70121-2627-5) * 2 mL in 1 VIAL (70121-1... | Risperidone | Amneal Pharmaceuticals LLC | 2025-09-08 |
| 70121-2628-05 | 1 KIT in 1 CARTON (70121-2628-5) * 2 mL in 1 VIAL (70121-1... | Risperidone | Amneal Pharmaceuticals LLC | 2025-09-08 |
Observed labelers:
Amneal Pharmaceuticals LLC (4) ·
Janssen Pharmaceuticals, Inc. (4) ·
Teva Pharmaceuticals, Inc. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2794 | Inj risperdal consta, 0.5 mg | 11 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.